Copied
 
 
Formål
Formål
Selskabets formål er at drive forskning, udvikling, produktion og handel med biologiske løsninger, herunder enzymer, mikroorganismer og andre bioteknologiske processer og produkter samt drive virksomhed, der efter bestyrelsens nærmere bestemmelse står i forbindelse hermed. Selskabet tilstræber at drive sin virksomhed på bæredygtig og ansvarlig vis, herunder i økonomisk, miljømæssig og social henseende.
Sidst opdateret den 25.02.2015 og angivet som gældende fra 26.02.2014 (3712 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 25.02.2015 og angivet som gældende fra 13.11.2000 (8565 dage).
Ingen historik.
Branche
Branche
Fremstilling af andre organiske basiskemikalier (201400).
Sidst opdateret den 25.12.2007 og angivet som gældende fra 01.01.2008 (5960 dage).
HistorikStartStop
Fremstilling af andre organiske basiskemikalier (201400)01.01.2008
Fremstilling af andre organiske basiskemikalier (241400)13.11.200031.12.2007
Revision
Revisionfravalgt
false.
Sidst opdateret den 11.03.2015 og angivet som gældende fra 13.11.2000 (8565 dage).
Ingen historik.
Form
Virksomhedsform
60.
Sidst opdateret den 22.11.2013 og angivet som gældende fra 13.11.2000 (8565 dage).
Ingen historik.
Kontakt
Ingen nuværende registrering.
Ingen historik.
Telefon
Ingen nuværende registrering.
Ingen historik.
Navne
Ingen historik.
Binavne
Binavne
Novonesis A/S.
Sidst opdateret den 04.03.2024 og angivet som gældende fra 04.03.2024 (53 dage).
Ingen historik.
Tegningsregel
Tegningsregel
Selskabet tegnes af to anmeldte direktører i forening eller af en anmeldt direktør sammen med bestyrelsens formand eller næstformand eller af den samlede bestyrelse.
Sidst opdateret den 25.02.2015 og angivet som gældende fra 26.02.2014 (3712 dage).
Fortolkning (3 tegningsmuligheder)
to anmeldte direktører +
en anmeldt direktør + formanden eller næstformanden
bestyrelsen
Ingen historik.
Ansatte
26.04.2024
Kapital
26.04.2024
Fra årsrapport
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:33771231
Beskrivelse af revisor:State Authorized Public Accountant
Virksomhedens regnskabsklasse:Reporting class D
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditor’s responsibilities for the audit of the Financial Statements and the Environmental, Social and Governance Data section of our report. We believe that the audit evidence we have obtained is sucient and appropriate to provide a basis for our opinion. IndependenceWe are independent of the Group in accordance with the International Ethics Standards Board for Accountants’ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark. We have also fullled our other ethical responsibilities in accordance with the IESBA Code. To the best of our knowledge and belief, prohibited non-audit services referred to in Article 5(1) of Regulation (EU) No 537/2014 were not provided,except for an insignicant breach that was reported to the Audit Committee and which did not aect our independence. AppointmentWe were appointed as auditors of Novozymes A/S for the rst time aer the initial public oering on March 21, 2001. We have been reappointed annually by shareholder resolution for a total period of uninterrupted engagement of 20 years, including the nancial year 2020.
Konklusion (revision):In our opinion, the Consolidated Financial Statements give a true and fair view of the Group’s nancial position at December 31, 2020 and of the results of the Group’s operations and cash ows for the nancial year January 1 to December 31, 2020 in accordance with International Financial Reporting Standards as adopted by the EU and further requirements in the Danish Financial Statements Act. Moreover, in our opinion, the Parent Company Financial Statements give a true and fair view of the Parent Company’s nancial position at December 31, 2020 and of the results of the Parent Company’s operations for the nancial year January 1 to December 31, 2020 in accordance with the Danish Financial Statements Act. In our opinion, the Consolidated environmental data and the Consolidated social and governance data for the nancial year January 1 to December 31, 2020 are prepared in accordance with the accounting policies for the Consolidated environmental data and the Consolidated social and governance data. Our opinions are consistent with our Auditor’s Long-form Report to the Audit Committee and the Board of Directors. What we have auditedThe Consolidated Financial Statements of Novozymes A/S, pages 52-60 and 65-116, for the nancial year January 1 to December 31, 2020 comprise the consolidated income statement and statement of comprehensive income, the consolidated balance sheet, the consolidated statement of shareholders’ equity, the consolidated statement of cash ows and the notes, including signicant accounting policies. The Parent Company Financial Statements of Novozymes A/S, pages 143-158, for the nancial year January 1 to December 31, 2020 comprise the income statement, the balance sheet, the statement of changes in equity and the notes, including signicant accounting policies. Collectively referred to as the “Financial Statements”. The Consolidated environmental data and the Consolidated social and governance data of Novozymes A/S, pages 61-64 and 117-137, for the nancial year January 1 to December 31, 2020 comprise the environmental performance and consolidated environmental data, the social and governance performance and consolidated social and governance data and the related notes, including signicant accounting policies. These are collectively referred to as the “Environmental, Social and Governance Data. ”
Udtalelse om ledelsesberetningen (revision):Management is responsible for Management’s Review, pages 3-51. Our opinion on the Financial Statements and on the Environmental, Social and Governance Data døs not cover Management’s Review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the Financial Statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the Financial Statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. Moreover, we considered whether Management’s Review includes the disclosures required by the Danish Financial Statements Act. Based on the work we have performed, in our view, Management’s Review is in accordance with the Consolidated Financial Statements, the Parent Company Financial Statements, and the Environmental, Social and Governance Data, and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement in Management’s Review.
Bibranche
Bibranche
Udlejning af erhvervsejendomme.
Sidst opdateret den 29.06.2017 og angivet som gældende fra 01.01.2008 (5960 dage).
Ingen historik.
Børsnoteret
26.04.2024
Børsnoteret
true.
Sidst opdateret den 25.02.2015 og angivet som gældende fra 01.01.2005 (7055 dage).
Ingen historik.
Hjemmeside
26.04.2024
Ingen nuværende registrering.
Ingen historik.